Prospective, multicentric, open label, clinical study to evaluate efficacy and safety of R-TPR-020 in patients undergoing treatment for infertility.

Trial Profile

Prospective, multicentric, open label, clinical study to evaluate efficacy and safety of R-TPR-020 in patients undergoing treatment for infertility.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2016

At a glance

  • Drugs Choriogonadotropin alfa (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Sponsors Reliance Life Sciences
  • Most Recent Events

    • 07 Jul 2010 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 13 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top